摘要
临床上对他汀类降脂疗效差异的认识尚不充分,与其相关的机制也值得进一步探讨。本文将主要探讨他汀类药在心血管疾病治疗中的应用。
二级参考文献34
-
1Undas A. Brummel Ziedins KE, Potaezek DP, et al. Atorvastatin and quinapril inhibit therapy[J].J Thromb Haemost, 2006,4(11 ) : 2397-2404.
-
2罗远英,腾日添.那普利联用他汀药物治疗高血压远期疗效观察[J].中国现代医学杂志,2008,10(9):61-62.
-
3苟连平,吕湛,秦俭,等.洛伐他汀对急性冠脉综合征患者外周血单核细胞ABCAl蛋白表达的影响[J].中华心血管病杂志,2008,6(1):8-10.
-
4Venero CV, Thompson PD. Managing statin myopathy[J]. Endocrinol Metab Clin North Am,2009,38(1):121-135.
-
5Xia Sheng,Michael J. Murphy,Thomas M. MacDonald,Li Wei.Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study[J].European Journal of Clinical Pharmacology.2012(8)
-
6KNOPP R H,D’’EMDEN M,SMILDE J G,et al.Efficacyand safety of atorvastatin in the prevention of cardiovascularend points in subjects with type 2 diabetes:the AtorvastatinStudy for Prevention of Coronary Heart Disease Endpoints innon-insulin-dependent diabetes mellitus(ASPEN)[].Diabetes Care.2006
-
7C Wanner,V Krane,W Marz,M Olschewski,HG Asmus,W Kramer.Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics[].Kidney Blood Press Res.2004
-
8European Association for Cardiovascular Prevention & Rehabilitation,Reiner Z,Catapano AL,et al.ESC/EAS Guidelines for the management of dyslipidaemias ? The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[].European Heart Journal.2011
-
9De Berardis G,Sacco M,Evangelista V,Filippi A,Giorda CB,Tognoni Get al.Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D):Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated wi[].Trials.2007
-
10Athyros,V.G.,Mikhailidis,D.P.,Papageorgiou,A.A.,Bouloukos,V.I.,Pehlivanidis,A.N.,Symeonides,A.N.,Kakafika,A.I.,Daskalopulou,S.S.,Elisaf,M.Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study[].Platelets.2005
共引文献19
-
1刘英.观察他汀类与心血管药物配伍疗效及安全性[J].医学信息（医学与计算机应用）,2016,29(27):274-275.
-
2黄良燕,王俊.阿托伐他汀对2型糖尿病患者血脂和血清超敏C-反应蛋白、白介素-6、8水平的影响[J].中国现代医生,2014,52(1):50-52. 被引量：3
-
3吴剑利,王俊.瑞舒伐他汀对2型糖尿病患者的降脂疗效及血管内皮功能的影响[J].中国现代医生,2014,52(6):63-65. 被引量：6
-
4张天毅,闻成艳.他汀类药物治疗心血管疾病依从性相关因素临床分析[J].中国医学工程,2014,22(2):7-8. 被引量：16
-
5赵文萃,张艳萍,房颖.辛伐他汀治疗急性心肌梗死的作用机制研究[J].中国药房,2015,26(6):763-766. 被引量：6
-
6胡明光.中山市坦洲医院15460张超说明书处方的用药分析[J].中国医院用药评价与分析,2015,15(2):228-230. 被引量：2
-
7龙志伟,廖彧,巫建芳,林绍怡.阿托伐他汀钙治疗糖尿病合并冠心病的效果及对患者生活质量的影响[J].白求恩医学杂志,2015,13(3):240-242. 被引量：7
-
8袁红.阿托伐他汀钙治疗慢性心力衰竭的疗效观察[J].中国医药指南,2015,13(27):113-113. 被引量：1
-
9陈华.阿托伐他汀强化治疗2型糖尿病患者的调脂疗效及对血管内皮功能的影响[J].中国药师,2015,18(11):1944-1946. 被引量：8
-
10潘永源,赵虹,王立,邢华.颈动脉超声评价血脂康对糖尿病患者颈动脉斑块的影响[J].中国临床药学杂志,2016,25(2):96-98. 被引量：3
同被引文献4
-
1欧吐红,娜几娜·吾格提,艾力曼·马合木提,等.他汀类药在心血管疾病治疗中的应用研究[J].医学信息,2015,(15):267-268.
-
2The package petrels. Statins in clinical application and progress in the treatment of cardiovaChina medical frontier,2013,(6): 18-19.
-
3Chen Lingling Clinical analysis of factors affecting the compliance of statins in the treatment of cardiovascula Chine se modem doctor,2011,49 (12): 128-130.
-
4张伟华.他汀类联合心血管药物治疗心血管疾病的疗效分析[J].中西医结合心血管病电子杂志,2014,2(18):141-141. 被引量：4
